论文信息 - An open-label randomized phase II trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) compared to carboplatin and paclitaxel in patients with previously untreated carcinoma of unknown primary. - 字舞流文

An open-label randomized phase II trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) compared to carboplatin and paclitaxel in patients with previously untreated carcinoma of unknown primary.

J. Hainsworth | K. Fizazi | G. Daugaard | M. Stahl | G. Rodriguez | D. Allouache | D. Braumann | J. Rubinsak | G. Huebner | L. Fuglsang